The Structural Dynamics, Complexity of Interactions, and Functions in Cancer of Multi-SAM Containing Proteins

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Jun 10

PMID 37296980

Authors

Christopher M Clements

Morkos A Henen

Beat Vogeli

Yiqun G Shellman

Affiliations

Soon will be listed here.

Abstract

SAM domains are crucial mediators of diverse interactions, including those important for tumorigenesis or metastasis of cancers, and thus SAM domains can be attractive targets for developing cancer therapies. This review aims to explore the literature, especially on the recent findings of the structural dynamics, regulation, and functions of SAM domains in proteins containing more than one SAM (multi-SAM containing proteins, MSCPs). The topics here include how intrinsic disorder of some SAMs and an additional SAM domain in MSCPs increase the complexity of their interactions and oligomerization arrangements. Many similarities exist among these MSCPs, including their effects on cancer cell adhesion, migration, and metastasis. In addition, they are all involved in some types of receptor-mediated signaling and neurology-related functions or diseases, although the specific receptors and functions vary. This review also provides a simple outline of methods for studying protein domains, which may help non-structural biologists to reach out and build new collaborations to study their favorite protein domains/regions. Overall, this review aims to provide representative examples of various scenarios that may provide clues to better understand the roles of SAM domains and MSCPs in cancer in general.

Citing Articles

Sam-Sam Association Between EphA2 and SASH1: In Silico Studies of Cancer-Linked Mutations.

Vincenzi M, Mercurio F, Autiero I, Leone M Molecules. 2025; 30(3).

PMID: 39942820 PMC: 11820823. DOI: 10.3390/molecules30030718.

Risk of Sperm Disorders and Impaired Fertility in Frozen-Thawed Bull Semen: A Genome-Wide Association Study.

Dementieva N, Dysin A, Shcherbakov Y, Nikitkina E, Musidray A, Petrova A Animals (Basel). 2024; 14(2).

PMID: 38254422 PMC: 10812825. DOI: 10.3390/ani14020251.

References

Kukuk L, Dingley A, Granzin J, Nagel-Steger L, Thiagarajan-Rosenkranz P, Ciupka D . Structure of the SLy1 SAM homodimer reveals a new interface for SAM domain self-association. Sci Rep. 2019; 9(1):54. PMC: 6328559. DOI: 10.1038/s41598-018-37185-3. View

Emaduddin M, Edelmann M, Kessler B, Feller S . Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells. Cell Commun Signal. 2008; 6:7. PMC: 2584000. DOI: 10.1186/1478-811X-6-7. View

Kim C, Bowie J . SAM domains: uniform structure, diversity of function. Trends Biochem Sci. 2003; 28(12):625-8. DOI: 10.1016/j.tibs.2003.11.001. View

Clements C, Vogeli B, Shellman Y, Henen M . Solution NMR backbone assignment of the SASH1 SLy proteins associated disordered region (SPIDER). Biomol NMR Assign. 2023; 17(1):151-157. PMC: 10291481. DOI: 10.1007/s12104-023-10134-6. View

Wang Y, Shang Y, Li J, Chen W, Li G, Wan J . Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions. Elife. 2018; 7. PMC: 5993539. DOI: 10.7554/eLife.35677. View

Green J, Gardner C, Wharton R, Aggarwal A . RNA recognition via the SAM domain of Smaug. Mol Cell. 2003; 11(6):1537-48. DOI: 10.1016/s1097-2765(03)00178-3. View

Shen J, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K . Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res. 2007; 67(6):2552-8. PMC: 2569966. DOI: 10.1158/0008-5472.CAN-06-3870. View

Huang X, Gollin S, Raja S, Godfrey T . High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A. 2002; 99(17):11369-74. PMC: 123263. DOI: 10.1073/pnas.172285799. View

Younis R, Taylor R, Beardsley P, McClay J . The gene and its associated phenotypes: focus on CNS drug response. Pharmacogenomics. 2019; 20(9):669-684. PMC: 6912848. DOI: 10.2217/pgs-2019-0015. View

10.

Lee H, Noh H, Mun J, Gu C, Sever S, Park S . Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis. Nat Commun. 2016; 7:12799. PMC: 5027278. DOI: 10.1038/ncomms12799. View

11.

Yeh I, Botton T, Talevich E, Shain A, Sparatta A, De la Fouchardiere A . Activating MET kinase rearrangements in melanoma and Spitz tumours. Nat Commun. 2015; 6:7174. PMC: 4446791. DOI: 10.1038/ncomms8174. View

12.

von Thun A, Birtwistle M, Kalna G, Grindlay J, Strachan D, Kolch W . ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-β2. J Cell Sci. 2012; 125(Pt 6):1465-77. DOI: 10.1242/jcs.092916. View

13.

Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I . Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014; 5:3116. PMC: 4084638. DOI: 10.1038/ncomms4116. View

14.

Qiao F, Bowie J . The many faces of SAM. Sci STKE. 2005; 2005(286):re7. DOI: 10.1126/stke.2862005re7. View

15.

Sporny M, Guez-Haddad J, Lebendiker M, Ulisse V, Volf A, Mim C . Structural Evidence for an Octameric Ring Arrangement of SARM1. J Mol Biol. 2019; 431(19):3591-3605. DOI: 10.1016/j.jmb.2019.06.030. View

16.

Li D, Yang R, Yang L, Wang D, Zhou X, Sun Y . circANKS1B regulates FOXM1 expression and promotes cell migration and invasion by functioning as a sponge of the miR-149 in colorectal cancer. Onco Targets Ther. 2019; 12:4065-4073. PMC: 6536817. DOI: 10.2147/OTT.S201310. View

17.

Arora S, Scott A, Janes P . Eph Receptors in Cancer. Biomedicines. 2023; 11(2). PMC: 9953285. DOI: 10.3390/biomedicines11020315. View

18.

Pehkonen H, de Curtis I, Monni O . Liprins in oncogenic signaling and cancer cell adhesion. Oncogene. 2021; 40(46):6406-6416. PMC: 8602034. DOI: 10.1038/s41388-021-02048-1. View

19.

Coulombe P, Paliouras G, Clayton A, Hussainkhel A, Fuller M, Jovanovic V . Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling. Cell Rep. 2019; 27(6):1769-1780.e4. DOI: 10.1016/j.celrep.2019.04.039. View

20.

Yang L, Zhang H, Yao Q, Yan Y, Wu R, Liu M . Clinical Significance of SASH1 Expression in Glioma. Dis Markers. 2015; 2015:383046. PMC: 4575719. DOI: 10.1155/2015/383046. View